Introduction Royal Care Super Specialty Hospital began its journey as a 50-bed multi-specialty hospital on May 1, 2015, in Coimbatore, Tamil Nadu. Within a year, the hospital gained significant recognition for its quality of care, becoming preferred healthcare destination for many in western Tamil Nadu. The hospital窶冱 commitment to excellence necessitated expansion, leading to the establishment of a larger and more comprehensive tertiary care unit. Expansion and Infrastructure Recognizing the need for a state-of-the-art facility, Royal Care Super Specialty Hospital embarked on an ambitious expansion project. A 750-bed ultramodern facility was constructed at Neelambur, Coimbatore, within a record time of 400 days. The first phase, comprising 300 beds, was inaugurated in November 2016. Spanning over 300,0 square feet, the facility is equipped with the latest medical technologies and infrastructure to provide comprehensive healthcare services under one roof. Pioneering Medical Advances...
Checking authentication...
Checking authentication...
P&L Statement | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Revenue | 221 | 301 | 305 | 333 |
Cost of Material Consumed | 70 | 97 | 98 | 106 |
Gross Margins | 68.33 | 67.77 | 67.87 | 68.17 |
Change in Inventory | - | - | - | -2 |
Employee Benefit Expenses | 36 | 53 | 54 | 54 |
Other Expenses | 60 | 83 | 92 | 108 |
EBITDA | 55 | 68 | 61 | 67 |
OPM | 24.89 | 22.59 | 20 | 20.12 |
Other Income | 3 | 4 | 5 | 5 |
Finance Cost | 29 | 27 | 27 | 22 |
D&A | 25 | 24 | 24 | 25 |
EBIT | 30 | 44 | 37 | 42 |
EBIT Margins | 13.57 | 14.62 | 12.13 | 12.61 |
PBT | 4 | 21 | 16 | 24 |
PBT Margins | 1.81 | 6.98 | 5.25 | 7.21 |
Tax | - | - | - | - |
PAT | 4 | 21 | 16 | 24 |
NPM | 1.81 | 6.98 | 5.25 | 7.21 |
EPS | 0.24 | 1.28 | 0.97 | 1.4 |
Financial Ratios | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Operating Profit Margin | 24.89 | 22.59 | 20 | 20.12 |
Net Profit Margin | 1.81 | 6.98 | 5.25 | 7.21 |
Earning Per Share (Diluted) | 0.24 | 1.28 | 0.97 | 1.4 |
Promoters | Designation | Experience | Linkedin Profile |
---|---|---|---|
Dr. K. Madeswaran | Chairman & MD | 25+ | - |
Dr. K. Chockalingam | Director | 25+ | - |
Sri. T.Balachander | Director & CFO | 25+ | - |
Review comprehensive annual business overviews and performance summaries
Year | Report Title | Report Type | Action |
---|---|---|---|
2024 | Royalcare Super Speciality Hospitals Shares | Annual Report | View Report |
2023 | Royalcare Super Speciality Hospitals Shares | Annual Report | View Report |
2021 | Royalcare Super Speciality Hospitals Shares | Annual Report | View Report |
Access essential information and documents to make informed investment decisions
Stay updated with upcoming events, conferences, and announcements
Access quarterly and half-yearly financial statements and reports
Download comprehensive annual reports and financial summaries
Access investor presentations, corporate briefings, and slideshows
The current market price of Royalcare Super Speciality Hospitals unlisted shares is ₹125 per share.
The minimum lot size is - shares, and trades must be placed in multiples of this.
The shares have traded as high as ₹- and as low as ₹- over the past year.
The shares are held in - depositories under ISIN INE02C801010.
Royalcare Super Speciality Hospitals Shares's market capitalization is approximately ₹ 1676 crore.
The company has P/E ratio of 70, P/B ratio of 8.17, Debt-to-Equity ratio of 1.49, ROE of 12.31%.
The book value of Royalcare Super Speciality Hospitals Shares is ₹11.99 per share.
The face value of Royalcare Super Speciality Hospitals unlisted shares is ₹10 per share.
Royalcare Super Speciality Hospitals Shares has 171017768 shares outstanding.
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.